{"database": "openregs", "table": "documents", "rows": [["FDA-2013-D-1630-0008", "FDA", "FDA-2013-D-1630", "Draft Guidance for Industry on Qualification for the Use of\nGalactomannan in Serum and Bronchoalveolar Lavage Fluid", "Other", "Guidance", "2014-10-27T04:00:00Z", 2014, 10, "2014-10-27T04:00:00Z", null, "2024-11-07T23:09:40Z", null, 1, 0, "09000064818ff0ae"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-D-1630-0008"], "units": {}, "query_ms": 44.21478894073516, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}